![SPIRIVA (tiotropium) Respimat inhaler device with cap removed while releasing solution into the air plus logo and male patient SPIRIVA (tiotropium) Respimat inhaler device with cap removed while releasing solution into the air plus logo and male patient](https://pro.boehringer-ingelheim.com/uk/themes/custom/uk_hcp/images/respiratory/spiolto-respimat/spiolto-respimat-for-copd.png)
SPIRIVA® Respimat® (tiotropium)
for severe asthma
SPIRIVA® Respimat® is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.
![SPIOLTO (Tiotropium + olodaterol) Respimat inhaler device with cap removed while releasing solution into the air plus logo and female patient SPIOLTO (Tiotropium + olodaterol) Respimat inhaler device with cap removed while releasing solution into the air plus logo and female patient](https://pro.boehringer-ingelheim.com/uk/themes/custom/uk_hcp/images/respiratory/spiolto-respimat/Spiriva-respimat-(tiotropium).png)
SPIOLTO® Respimat® (tiotropium + olodaterol) for COPD
SPIOLTO® Respimat® is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.
COPD, chronic obstructive pulmonary disease; LAMA, long-acting muscarinic receptor antagonist; LABA, long-acting beta agonist; DPI, dry powder inhaler; SMI, soft mist inhaler.